Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis

被引:12
|
作者
Huijgen, R. [1 ]
Stork, A. D. M. [1 ]
Defesche, J. C. [1 ]
Peter, J. [1 ]
Alonso, R. [2 ]
Cuevas, A. [3 ]
Kastelein, J. J. P. [1 ]
Duran, M. [4 ]
Stroes, E. S. G. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Fdn Jimenez Diaz, Dept Internal Med, E-28040 Madrid, Spain
[3] Clin Las Condes, Dept Clin Nutr, Santiago, Chile
[4] Univ Amsterdam, Acad Med Ctr, Dept Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands
关键词
cerebrotendinous; cholestanol; familial hypercholesterolemia; LDL cholesterol; xanthoma; xanthomatosis; DENSITY-LIPOPROTEIN RECEPTOR; CHENODEOXYCHOLIC ACID; APOLIPOPROTEIN-B; TENDON XANTHOMAS; MUTATIONS; INDIVIDUALS; CHOLESTANOL; UPDATE; GENES;
D O I
10.1111/j.1399-0004.2011.01793.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Two unrelated individuals were referred to Lipid Clinics in The Netherlands and Chile with extreme xanthomatosis and hypercholesterolemia. Both were diagnosed with heterozygous familial hypercholesterolemia (heFH) after molecular genetic analysis of the low-density lipoprotein (LDL) receptor gene. Since heFH by itself could not account for the massive xanthomas, the presence of an additional hereditary lipid or lipoprotein disorder was suspected. Further genetic analysis revealed homozygozity for mutations in the sterol 27-hydroxylase gene, confirming the diagnosis of cerebrotendinous xanthomatosis (CTX). Markedly, the typical neurological manifestations of CTX were absent, suggestive of a protective role of LDL-receptor deficiency against the severe neurological consequences of CTX.
引用
收藏
页码:24 / 28
页数:5
相关论文
共 50 条
  • [31] Cerebrotendinous xanthomatosis and anaesthesia
    Habaragamuwa, B. W. P.
    Bajekal, R.
    BRITISH JOURNAL OF ANAESTHESIA, 2010, 105 (02) : 237 - 238
  • [32] CHOLESTANOL FORMATION IN CEREBROTENDINOUS XANTHOMATOSIS AND SITOSTEROLEMIA WITH XANTHOMATOSIS
    SALEN, G
    SHEFER, S
    TINT, GS
    HORAK, E
    CLINICAL RESEARCH, 1985, 33 (02): : A574 - A574
  • [33] PARKINSONISM IN CEREBROTENDINOUS XANTHOMATOSIS
    FUJIYAMA, J
    KURIYAMA, M
    YOSHIDOME, H
    SUEHARA, M
    EIRAKU, N
    KASHIO, N
    OSAME, M
    JAPANESE JOURNAL OF MEDICINE, 1991, 30 (02) : 189 - 192
  • [34] CEREBROTENDINOUS XANTHOMATOSIS: REPORT OF 4 PATIENTS
    Ferrandiz-Pulido, C.
    Bartralot, R.
    Giros, M.
    Bassas, P.
    Heras, C.
    Bodet, D.
    Savall, R.
    Garcia-Patos, V.
    ACTAS DERMO-SIFILIOGRAFICAS, 2009, 100 (03): : 222 - 226
  • [35] CHOLESTYRAMINE THERAPY IN PATIENTS HOMOZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA (FAMILIAL HYPERCHOLESTEROLEMIC XANTHOMATOSIS)
    KHACHADURIAN, AK
    DEMIRJIA.ZN
    JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1968, 8 (01): : 177 - +
  • [36] Patients with Lately Diagnosed Cerebrotendinous Xanthomatosis
    Yunisova, Gulshan
    Tufekcioglu, Zeynep
    Dogu, Okan
    Bilgic, Basar
    Kaleagasi, Hakan
    Akca Kalem, Sukriye
    Lohmann, Ebba
    Gurvit, Hakan I.
    Emre, Murat
    Hanagasi, Hasmet A.
    NEURODEGENERATIVE DISEASES, 2020, 19 (5-6) : 218 - 224
  • [37] Update on cerebrotendinous xanthomatosis
    DeBarber, Andrea E.
    Duell, P. Barton
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (02) : 123 - 131
  • [38] Cerebrotendinous xanthomatosis in Spain
    Pilo, B.
    Sobrido, M. J.
    Gonzalez Martin-Moro, J.
    Barrero, F.
    Lustres, M.
    Navarro, C.
    Pardo, J.
    Arias, M.
    Jimenez Escrig, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 295 - 295
  • [39] Cerebrotendinous xanthomatosis revisited
    Baghbanian, Seyed Mohammad
    Amiri, Mohammad Reza Mahdavi
    Majidi, Hadi
    PRACTICAL NEUROLOGY, 2021, 21 (03) : 243 - 245
  • [40] Screening for cerebrotendinous xanthomatosis
    Pitt, James J.
    Peters, Heidi
    JOURNAL OF INHERITED METABOLIC DISEASE, 2015, 38 (02) : 369 - 369